title: [Glycated albumin level and its influential factors in type 2 diabetes mellitus].
abstract: OBJECTIVE
  To provide evidence for assessing glycated albumin (GA) appropriately cliniccally through determining the GA level of type 2 diabetes mellitus (DM) patients and analyzing its influential factors.
  
  
  METHODS
  Continuous glucose monitor system was used to monitor the levels of fasting plasmic glucose (FPG), 2-hour post-prandial plasmic glucose (2hPG), GA, and glycated hemoglobin (HbA1c) in 445 type 2 DM in-patients.
  
  
  RESULTS
  (1) The mean GA value was 24.9% +/- 7.0% and the mean HbA1c was 8.9% +/- 2.2%. (2) GA value was associated with HbA1c (P < 0.001). GA was positively correlated with FPG, 2hPG, and mean blood glucose (MBG) (all P < 0.01). (3) GA value was negatively correlated with BMI (P < 0.01). (4) Multiple stepwise regression analysis showed that HbA1c, BMI, and FPG were the main influential factors of GA.
  
  
  CONCLUSIONS
  (1) GA value has good relationship with HbA1c, a golden standard to reflect the glycemic control in a long period. (2) BMI should be concerned when assessing GA value of DM patients, especially of the obese and thin subjects.
authors.affiliation: Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Jiaotong University Affiliated No 6 People Hospital, Shanghai, China.
authors.forename: Qing
authors.initials: Q
authors.lastname: Li
authors.forename: Song-Hua
authors.initials: SH
authors.lastname: Wu
authors.forename: Jie-Min
authors.initials: JM
authors.lastname: Pan
authors.forename: Jun-Ling
authors.initials: JL
authors.lastname: Tang
authors.forename: Yang
authors.initials: Y
authors.lastname: Zhang
authors.forename: Hui-Juan
authors.initials: HJ
authors.lastname: Lu
authors.forename: Yu-Qian
authors.initials: YQ
authors.lastname: Bao
authors.forename: Wei-Ping
authors.initials: WP
authors.lastname: Jia
authors.forename: Kun-San
authors.initials: KS
authors.lastname: Xiang
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000473:pathology; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D017127:Glycation End Products, Advanced; D006031:Glycosylation; D006801:Humans; D007297:Inpatients / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D012709:Serum Albumin / Q000378:metabolism*; D000093423:Glycated Serum Albumin
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D017127:Glycation End Products, Advanced; D012709:Serum Albumin; D000093423:Glycated Serum Albumin